Athena Countouriotis

Board Member

Equibles does not estimate personal net worth.

Get an email with a short summary when Passage BIO, Inc. publishes a filing, an earnings call transcript or a press release.

Get PASG alerts

About Athena Countouriotis

Athena Countouriotis is recorded as Board Member at Passage BIO, Inc. (PASG) since September 16, 2025. Passage BIO, Inc. reported in an 8-K filed September 18, 2025 that Athena Countouriotis was appointed member of the Audit Committee, effective September 16, 2025. Passage BIO, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Passage BIO, Inc. includes Peter Smith, Ph.D. (CEO), William Chou (CEO and Board Member), William Chou, M.D. (CEO and Board Member) and 6 others.

“In connection with Mr. Islam's resignation, the Board appointed Athena Countouriotis, M.D., as a member of the Audit Committee to fill the vacancy left by Mr. Islam, and reduced the size of the Board from eight to seven members, effective as of the Resignation Date.”

Passage BIO, Inc. Form 8-K, filed September 18, 2025 · Read the filing

Affiliation history

Passage BIO, Inc. (PASG)
Board Member

SEC 8-K

Current
2025-09-16–present

Company network

Passage BIO, Inc.

PASG

Current role

Biotechnology · Healthcare

Board Member

2025-09-16–present

Leadership on record at Passage BIO, Inc.

Peter Smith, Ph.D. CEO
William Chou CEO, Board Member
William Chou, M.D. CEO, Board Member
Maxine Gowen Chairman
Kathleen Borthwick CFO
Dolan Sondhi Board Member
Dr. Maxine Gowen Board Member
Dr. Michael Kamarck Board Member
Thomas Kassberg Board Member

Recent activity

Executive change Appointed: member of the Audit Committee Passage BIO, Inc. (PASG)
2025-09-16